Literature DB >> 25454733

Myotonic discharges discriminate chloride from sodium muscle channelopathies.

Gea Drost1, Bas C Stunnenberg2, Jeroen Trip3, George Borm4, Kevin C McGill5, Ieke H B Ginjaar6, Arendina W van der Kooi2, Machiel J Zwarts7, Baziel G M van Engelen2, Catharina G Faber8, Dick F Stegeman9, Zoia Lateva5.   

Abstract

Non-dystrophic myotonic syndromes represent a heterogeneous group of clinically quite similar diseases sharing the feature of myotonia. These syndromes can be separated into chloride and sodium channelopathies, with gene-defects in chloride or sodium channel proteins of the sarcolemmal membrane. Myotonia has its basis in an electrical instability of the sarcolemmal membrane. In the present study we examine the discriminative power of the resulting myotonic discharges for these disorders. Needle electromyography was performed by an electromyographer blinded for genetic diagnosis in 66 non-dystrophic myotonia patients (32 chloride and 34 sodium channelopathy). Five muscles in each patient were examined. Individual trains of myotonic discharges were extracted and analyzed with respect to firing characteristics. Myotonic discharge characteristics in the rectus femoris muscle almost perfectly discriminated chloride from sodium channelopathy patients. The first interdischarge interval as a single variable was longer than 30 ms in all but one of the chloride channelopathy patients and shorter than 30 ms in all of the sodium channelopathy patients. This resulted in a detection rate of over 95%. Myotonic discharges of a single muscle can be used to better guide toward a molecular diagnosis in non-dystrophic myotonic syndromes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chloride channelopathies; Diagnosis; Myotonic discharges; Needle electromyography; Non-dystrophic myotonic syndromes; Sodium channelopathies

Mesh:

Substances:

Year:  2014        PMID: 25454733     DOI: 10.1016/j.nmd.2014.09.014

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  4 in total

1.  Zebrafish needle EMG: a new tool for high-throughput drug screens.

Authors:  Sung-Joon Cho; Tai-Seung Nam; Donghak Byun; Seok-Yong Choi; Myeong-Kyu Kim; Sohee Kim
Journal:  J Neurophysiol       Date:  2015-07-15       Impact factor: 2.714

Review 2.  Guidelines on clinical presentation and management of nondystrophic myotonias.

Authors:  Bas C Stunnenberg; Samantha LoRusso; W David Arnold; Richard J Barohn; Stephen C Cannon; Bertrand Fontaine; Robert C Griggs; Michael G Hanna; Emma Matthews; Giovanni Meola; Valeria A Sansone; Jaya R Trivedi; Baziel G M van Engelen; Savine Vicart; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2020-05-27       Impact factor: 3.217

3.  Combined N-of-1 trials to investigate mexiletine in non-dystrophic myotonia using a Bayesian approach; study rationale and protocol.

Authors:  Bas C Stunnenberg; Willem Woertman; Joost Raaphorst; Jeffrey M Statland; Robert C Griggs; Janneke Timmermans; Christiaan G Saris; Bas J Schouwenberg; Hans M Groenewoud; Dick F Stegeman; Baziel G M van Engelen; Gea Drost; Gert Jan van der Wilt
Journal:  BMC Neurol       Date:  2015-03-25       Impact factor: 2.474

Review 4.  Genetic neurological channelopathies: molecular genetics and clinical phenotypes.

Authors:  J Spillane; D M Kullmann; M G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-11-11       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.